Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and survival data well above ...

Parkinson’s disease (PD) is entering a pivotal phase. For decades, treatment has centred on dopamine replacement to manage ...

Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and survival data well above standard of care benchmarks 50,000 advanced NSCLC diag ...

A new platform for studying mtDNA mutations implicated in human disease could help accelerate treatments for mitochondrial ...

SAB Biotherapeutics’ SAB-142 targets stage 2/3 type 1 diabetes, aiming to preserve beta-cell function. Click here to read my ...

A layered coating on delignified wood enables solar heat storage and electricity generation without carbonization, while ...

Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced ...

A biodegradable ionic hydrogel battery modeled on electric eel organs powers a nerve conduit that accelerates peripheral nerve regeneration without external energy.

French cultivated meat pioneer Parima, parent company of Gourmey and Vital Meat, has obtained regulatory clearance to sell ...

CaringKind, the leading expert in Alzheimer's and dementia care, and the Alzheimer's Disease Resource Center (ADRC), now an affiliate of CaringKind, today announced that CaringKind's Helpline is now ...

RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies, today announced the launch of Duracyte, a biotechnology ...

Jabil and HSE have formed a strategic collaboration to streamline the design, development, and scalable production of ...